
Market close: NZ shares make gentler decline than US markets amid AI sell-off
The NZX 50 fell 0.66% but ended the week up 1.48%.
Stories and analysis from The Northern Express Herald.
The S&P/NZX 50 closed at 13,720.26, up 0.16%.
Fisher & Paykel Healthcare drags the NZX 50 down 0.71%.
The S&P/NZX 50 Index closed at 13,797, up 86.83 points or 0.63%.
The S&P/NZX 50 Index closed at 13,710.17, up 18.84 points or 0.14%.
The OCR was held at 2.75% in a four-to-three vote; the NZ dollar fell after the decision.
The S&P/NZX 50 closed down 0.39% at 13,680.27 after a busy day of trading.
The NZX 50 closed down 0.09% and was flat for the week, while the Nasdaq tumbled.
Investors have priced in a 90% chance of a 25-basis-point OCR rise next week.
Ebos reaffirmed its 2027 operating earnings guidance of $635m-$655m.
Simplicity unseats the star performer in key category.
OPINION: Why election predictions are no basis for investment decisions.
The S&P/NZX 50 Index closed at 13,631.69, down 20.38 points or 0.15%.
The S&P/NZX 50 Index closed at 13,652.07, a decline of 101.66 points or 0.74%.
The conditional $221m Grand Hotel sale would take SkyCity’s asset sales to $295.5m.
The S&P/NZX50 Index closed at 13,832.8, up 72.4 points or 0.53%.
The NZX 50 rose 0.08% as the 10-year Government Bond yield eased.
OPINION: Raising NZ Super age to 67 will not solve the retirement funding challenge.
The S&P/NZX50 Index closed at 13,749.6, down 78.02 points, or 0.56%.
The S&P/NZX50 Index closed at 13,827.62, up 78.27 points or 0.57%.
Crimson waived its 90% acceptance threshold and will settle for 50.1%.
The S&P/NZX50 Index closed at 13,749.35, up 57.49 points or 0.42%.
The S&P/NZX50 Index closed at 13,691.85, up 7.8 points or 0.06%.
Ryman declined to a 16-year low, while Fisher & Paykel Healthcare is at an all-time high.
OPINION: How political party plans could change KiwiSaver balances.
Confidence climbed from plus 8 to plus 40 in the NZIER's latest quarterly survey.